Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Vitruvias Therapeutics Inc recalls Thyroid Tablets

Class Iofficial

FDA Class I

FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.

Hazard
Superpotent Drug
Products
  • Thyroid Tablets
Company
Vitruvias Therapeutics Inc
Where it was sold

US Nationwide.

Nationwide

Units affected
1955 bottles
About this recall
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.